Histanaz
- Product NDC
- 29978-129
- 11-digit product format
- 299780129
- Labeler code
- 29978
- Product ID
- 29978-129_5013a487-2901-ef02-e063-6394a90a2902
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Pseudoephedrine HCL, Pyrilamine Maleate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Capital Pharmaceutical, LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-09-08
- Substance
- PSEUDOEPHEDRINE HYDROCHLORIDE; PYRILAMINE MALEATE
- Active strength
- 60; 30 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Histanaz
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PSEUDOEPHEDRINE HYDROCHLORIDE | 60 mg/1 |
| PYRILAMINE MALEATE | 30 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6V9V2RYJ8N, R35D29L3ZA |
| Rxcui | 2727351 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 29978-129-10 | Histanaz | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 29978-129-10 | 29978012910 | 100 TABLET in 1 BOTTLE (29978-129-10) | 100 tablet | 2025-09-08 | No | No | Current |